Herbs (Global Traditional) · European
Lemon Verbena (Aloysia citrodora) (Aloysia citrodora)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Lemon verbena contains phenolic compounds including 3,4-dicaffeoylquinic acid that enhance antioxidant enzyme activity in laboratory studies. The herb's flavonoids boost superoxide dismutase, catalase, and glutathione peroxidase levels through cellular antioxidant pathways.
Lemon Verbena (Aloysia citrodora) is a perennial aromatic shrub native to South America, particularly Argentina and Chile, now cultivated globally in temperate regions. The herb is sourced from dried leaves containing phenolic compounds (verbascoside up to 83.54 mg/g dry weight), essential oils (citral, limonene), and flavonoids, extracted via drying for powders/infusions or hydrodistillation for essential oils.
No human clinical trials, RCTs, or meta-analyses were found for Lemon Verbena in the available research. Current evidence consists solely of phytochemical composition studies, in vitro antioxidant assays, and preliminary bioactivity research on isolated compounds like verbascoside and 3,4-dicaffeoylquinic acid.
No clinically studied dosage ranges are available as human trials are absent. Compositional studies reference verbascoside content up to 83.54 mg/g dry weight and total flavonoids at 27-39 mg CE/g DW, but therapeutic dosing protocols have not been established. Consult a healthcare provider before starting any new supplement.
Lemon verbena leaves are consumed primarily as an herbal infusion rather than a caloric food source, so macronutrient contribution is negligible per typical serving (2–3 g dried leaf per cup). Key bioactive compounds include: • **Phenylpropanoids**: Verbascoside (acteoside) is the dominant compound, typically 1.5–6.0% of dry leaf weight (~15–60 mg/g), a potent antioxidant with ORAC values among the highest recorded for herbal infusions. • **Volatile terpenoids (essential oil 0.1–0.5% of dry weight)**: Citral (geranial + neral) constitutes 30–45% of essential oil; limonene 5–15%; 1,8-cineole 3–8%; geraniol, linalool, and β-caryophyllene present in smaller fractions. • **Phenolic acids**: Chlorogenic acid (~1–3 mg/g dry weight), caffeic acid, 3,4-dicaffeoylquinic acid, and isoverbascoside (~0.3–1.5 mg/g). • **Flavonoids**: Luteolin-7-diglucuronide (~2–8 mg/g dry weight), apigenin-7-diglucuronide, chrysoeriol derivatives; total flavonoid content approximately 5–15 mg quercetin equivalents per gram dry leaf. • **Total polyphenol content**: Approximately 20–50 mg gallic acid equivalents (GAE) per gram of dried leaf, with aqueous infusions extracting roughly 40–60% of these compounds depending on steeping time and temperature. • **Minerals (per 100 g dried leaf, approximate)**: Potassium 800–1,200 mg; calcium 600–900 mg; magnesium 200–350 mg; iron 8–15 mg; manganese 3–7 mg; zinc 2–4 mg. Per single cup infusion, mineral contribution is minimal (typically <5% of daily values). • **Vitamins**: Trace amounts of vitamin C (~3–8 mg per 100 g fresh leaf); no significant B-vitamin or fat-soluble vitamin content. • **Fiber/Protein**: Dried leaves contain approximately 10–14% crude fiber and 5–8% crude protein by weight, but these are irrelevant at infusion-level consumption. • **Bioavailability notes**: Verbascoside undergoes extensive first-pass metabolism and is hydrolyzed to hydroxytyrosol and caffeic acid in the gut, which are the primary bioavailable metabolites (oral bioavailability of intact verbascoside is estimated at <5%). Citral and other volatile terpenes are partially lost during hot water infusion due to evaporation; covered steeping improves retention. Luteolin glucuronides require intestinal deconjugation for absorption, with moderate bioavailability compared to aglycone forms. Iron and mineral bioavailability from the infusion may be reduced by polyphenol chelation.
Lemon verbena's phenolic compounds, particularly 3,4-dicaffeoylquinic acid, upregulate antioxidant enzyme expression by activating Nrf2 transcription pathways. The flavonoids enhance superoxide dismutase, catalase, and glutathione peroxidase activity through direct enzyme modulation. These mechanisms collectively reduce oxidative stress markers in cellular environments.
Evidence for lemon verbena comes primarily from in vitro laboratory studies examining isolated compounds rather than human trials. Cell culture studies demonstrate enhanced antioxidant enzyme activity, but no clinical trials have established human efficacy or optimal dosing. The neuroprotective effects attributed to 3,4-dicaffeoylquinic acid are based solely on isolated compound research. More human studies are needed to validate therapeutic applications and determine effective dosage ranges.
Lemon verbena is generally recognized as safe when consumed as a culinary herb or tea in normal amounts. No significant drug interactions have been documented, though theoretical concerns exist with anticoagulant medications due to potential bleeding risk enhancement. Pregnant and breastfeeding women should avoid therapeutic doses due to insufficient safety data. Some individuals may experience mild digestive upset or allergic reactions to compounds in the Verbenaceae plant family.
